Enjoy complimentary customisation on priority with our Enterprise License!
The diabetes management devices market size is forecast to increase by USD 13.98 billion at a CAGR of 7.68% between 2023 and 2028. The market is experiencing significant growth due to the rising global burden of diabetes and the growing focus on artificial pancreas systems. These advanced devices, which include dedicated apps, continuous glucose monitors (CGM), transdermal sensors, and non-invasive glucose testing technologies like spectroscopy, aim to provide healthcare providers and users with valuable insights into glucose patterns and treatment plans. User-friendly interfaces and visual representations facilitate medication adherence and effective management of glucose levels. The market is also witnessing the integration of artificial intelligence and machine learning algorithms to improve accuracy and predictive capabilities. However, the prohibitive cost of diabetes care devices, including CGM systems, testing strips, and insulin pumps, remains a major challenge for market growth.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.